338 related articles for article (PubMed ID: 1947727)
1. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A
Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C
Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379
[TBL] [Abstract][Full Text] [Related]
3. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
[TBL] [Abstract][Full Text] [Related]
4. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
Nieminen MS; Mattila KJ; Aalto-Setälä K; Kuusi T; Kontula K; Kauppinen-Mäkelin R; Ehnholm C; Jauhiainen M; Valle M; Taskinen MR
Arterioscler Thromb; 1992 Jan; 12(1):58-69. PubMed ID: 1346250
[TBL] [Abstract][Full Text] [Related]
5. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study.
Srinivasan SR; Ehnholm C; Wattigney WA; Berenson GS
Atherosclerosis; 1996 Nov; 127(1):73-9. PubMed ID: 9006807
[TBL] [Abstract][Full Text] [Related]
6. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
[TBL] [Abstract][Full Text] [Related]
7. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
[TBL] [Abstract][Full Text] [Related]
8. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study.
Grönroos P; Raitakari OT; Kähönen M; Hutri-Kähönen N; Marniemi J; Viikari J; Lehtimäki T
Clin Chem Lab Med; 2007; 45(5):592-8. PubMed ID: 17484618
[TBL] [Abstract][Full Text] [Related]
9. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease.
Ford ES; Cooper RS; Simmons B; Castaner A
J Clin Epidemiol; 1990; 43(5):425-32. PubMed ID: 2109048
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E phenotypes in patients with coronary artery disease.
Miida T
Tohoku J Exp Med; 1990 Mar; 160(3):177-87. PubMed ID: 2353352
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study.
Kataoka S; Robbins DC; Cowan LD; Go O; Yeh JL; Devereux RB; Fabsitz RR; Lee ET; Welty TK; Howard BV
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):918-25. PubMed ID: 8696954
[TBL] [Abstract][Full Text] [Related]
13. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening.
Terry JG; Howard G; Mercuri M; Bond MG; Crouse JR
Stroke; 1996 Oct; 27(10):1755-9. PubMed ID: 8841324
[TBL] [Abstract][Full Text] [Related]
15. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study.
Luc G; Bard JM; Arveiler D; Evans A; Cambou JP; Bingham A; Amouyel P; Schaffer P; Ruidavets JB; Cambien F
Arterioscler Thromb; 1994 Sep; 14(9):1412-9. PubMed ID: 8068601
[TBL] [Abstract][Full Text] [Related]
16. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
[TBL] [Abstract][Full Text] [Related]
18. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
Petrovic D; Zorc M; Peterlin B
Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
[TBL] [Abstract][Full Text] [Related]
19. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study.
Lehtimäki T; Porkka K; Viikari J; Ehnholm C; Akerblom HK; Nikkari T
Pediatrics; 1994 Oct; 94(4 Pt 1):489-93. PubMed ID: 7936857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
